C95.12
Chronic leukemia of unspecified cell type, in relapse
Clinical Classification Guidelines
Medical Intelligence & Overview
Chronic leukemia refers to a slow-growing type of blood cancer that originates in the bone marrow, impacting blood cell production. The specific condition classified under ICD-10 code C95.12 pertains to a case of leukemia of unspecified cell type that has recurred after treatment. This diagnosis indicates that the disease has relapsed, meaning that the leukemia has returned following a period of remission. It's important for patients to understand the nature of this disease, potential causes, symptoms, and treatment options to better manage their health and work closely with healthcare providers.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting blood cell development Previous exposure to chemotherapy or radiation therapy Inherited genetic conditions or family history of blood cancers Environmental factors such as exposure to certain chemicals or toxins Age-related changes in blood cell production, typically occurring in older adults
Key Symptoms: Persistent fatigue or weakness Unexplained weight loss Fever or night sweats Frequent infections Enlarged lymph nodes, spleen, or liver Easy bruising or bleeding Bone or joint pain Shortness of breath in advanced cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis of chronic leukemia, especially in relapse, typically involves several steps to confirm the disease and its specifics. These may include:
Treatment Protocols: Managing relapse in chronic leukemia of unspecified cell type often involves a combination of therapies tailored to the patient’s overall health and disease characteristics. Treatment options may include:
Clinical Advice & FAQs
Billing Guidance
Is C95.12 a billable ICD-10 code?
Yes, C95.12 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C95.12?
Clinical documentation must specify the nature of Chronic leukemia of unspecified cell type, in relapse and any associated comorbidities for accurate reporting.
Cite this Clinical Reference